Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1087 of 5804
-
Can a new drug help myasthenia gravis patients ditch steroids?
Disease control Recruiting nowThis is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering schedule to reduce OCS use in adult participants with acetylcholine receptor positive (AChR+) generalized myasthenia gravis (g…
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New radiotracer aims to spot hidden cancers
Diagnosis Recruiting nowThe goal of this prospective, single-arm clinical trial is to evaluate the imaging performance and safety of an EpCAM-targeted radiotracer, \[68Ga\]Ga-PN-EpC1, in patients with epithelial tumors. The main questions it aims to answer are: * What is the sensitivity of \[68Ga\]Ga-…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Experimental DNA vaccine aims to train immune system against prostate cancer
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to learn whether an experimental vaccine called pTVG-HP ("vaccine" or "DNA vaccine"), combined with a drug called nivolumab can increase the cancer-fighting ability of a person's immune cells. The main question it aims to answer is whether the …
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
Could a special bike workout cut heart risks for spinal cord injury patients?
Disease control Recruiting nowProject Summary/Abstract Obesity and metabolic syndrome (obesity, dyslipidemia, hyperglycemia, hypertension) are epidemic in the spinal cord injured (SCI) population. A recent study assessing the body composition and metabolic syndrome rates of 72 motor complete chronic SCI indiv…
Phase: NA • Sponsor: William Carey University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo therapy offers hope for Hard-to-Treat breast cancer
Disease control Recruiting nowThis phase II trial tests how well tamoxifen and pegylated liposomal doxorubicin works in treating patients with triple negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or that has spread to nearby tissue o…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a blood pressure drug lift brain fog in depression?
Symptom relief Recruiting nowThe purpose of this study is to understand how a psychotropic medication called guanfacine affects brain network functioning in humans, and how this function interacts with cognitive impairments in people experiencing depressive symptoms.
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New drug SYS6043 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated with standard therapies. The main goals of the study are to understand how safe SYS6043 is, what side …
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to tackle PTSD and obesity in veterans with one program
Disease control Recruiting nowObesity and post-traumatic stress disorder (PTSD) are common among Veterans. PTSD increases risk for obesity, impacting functioning, health, quality of life, and premature mortality. Use of proven treatments for PTSD and obesity in VA is low. Furthermore, Veterans with PTSD lose …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could donor milk save tiny babies from deadly gut disease?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether supplementing with pasteurized donor human milk (pHDM) or preterm formula (PTF) when own mother's milk (OMM) is insufficient can improve outcomes in very preterm infants born before 29 weeks of gestation. It also aims to asse…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Glow-in-the-Dark dye could help surgeons spot brain tumors
Diagnosis Not yet recruitingParticipants in this research study are people who are likely to have, or have been diagnosed with a brain tumor, for which surgical removal (or "resection") is the standard of care treatment. The purpose of this study is to see whether a drug called SBK2-ICG can be used to locat…
Phase: PHASE1 • Sponsor: Tiffany Hodges • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New stent graft for aortic arch disease tracked for 10 years
Disease control Recruiting nowA prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug aims to scrub sticky proteins from heart muscle
Disease control Recruiting nowThe study is conducted in participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a heart disease that occurs in people with the disease ATTR amyloidosis. The purpose of this study is to see how radioactively labelled coramitug is taken up by the heart after administrat…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New obesity drug combo aims for greater weight loss
Disease control Recruiting nowThe purpose of this study is to: * evaluate the safety, tolerability, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of ALN-2232 in patients with obesity * evaluate the safety, tolerability, efficacy, PK, and PD of multiple doses of ALN-2232…
Phase: PHASE1, PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can virtual doula sessions and home monitoring prevent preeclampsia in black women?
Prevention ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participa…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
AI could replace biopsies for bladder cancer testing
Diagnosis ENROLLING_BY_INVITATIONThis study aims to build upon previous research by using artificial intelligence methods to fuse multimodal data from imaging and pathology to construct a predictive model for HER2 expression in urothelial carcinoma. The model's performance will be validated and optimized using a…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control ENROLLING_BY_INVITATIONThis multi-center, observational, post-intervention LTFU study will monitor for safety and efficacy of AAVAnc80- antiVEGF in individuals with vestibular schwannoma who have previously received an intracochlear administration of AAVAnc80-antiVEGF in an interventional clinical tria…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New imaging trick may speed up stroke treatment
Knowledge-focused Recruiting nowEndovascular thrombectomy (EVT) is the standard of care for acute ischemic stroke (AIS) caused by a large vessel occlusion. Successful recanalization is one of the most important factors for a good patient outcome, especially when obtained within 30 minutes from groin puncture, …
Phase: NA • Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Could a neck device tame PTSD symptoms?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of the gammaCore non-invasive vagus nerve stimulation (nVNS) device as an additional treatment for symptoms of post-traumatic stress disorder (PTSD) in adults. The vagus nerve connects the brain with man…
Phase: NA • Sponsor: Acacia Clinics • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New drug aims to boost brain energy in Parkinson's patients
Disease control Recruiting nowThe main goal of the study is to investigate how well the new drug SUL-238 works in Parkinson's Disease (PD). This is done by means of an MRS scan. An MRS scan is similar to a regular MRI scan. It will also learn about the safety of new drug SUL-238. The main questions it aims to…
Phase: PHASE2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Immune cells engineered to hunt thymus cancer show promise in early trial
Disease control Recruiting nowThis Phase 1/2 study evaluates the safety, tolerability, and preliminary efficacy of target-selected CAR-natural killer (CAR-NK) cells in adults with relapsed or refractory B2 thymoma or thymic carcinoma. Participants undergo centralized tumor antigen assessment (CD30, CD5, and m…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC